Google-backed research company Calico and biopharmaceutical company AbbVie...
Google-backed research company Calico and biopharmaceutical company AbbVie are planning to build a research and development center in the San Francisco Bay Area to develop anti-aging drugs, including those for neurodegeneration and cancer, said a Calico news release Wednesday (http://bit.ly/1nxeMaY).…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
The companies will each invest $250 million for the project and could each invest an additional $500 million, it said. AbbVie’s research and development experience will “complement Calico’s biotechnology expertise and innovative scientific approaches,” said Michael Severino, AbbVie chief scientific officer, in the release.